Jalalzadeh H, Indrakusuma R, Planken R N, Legemate D A, Koelemay M J W, Balm R
Department of Vascular Surgery, Academic Medical Center, Amsterdam, The Netherlands.
Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands.
Eur J Vasc Endovasc Surg. 2016 Sep;52(3):333-42. doi: 10.1016/j.ejvs.2016.05.002. Epub 2016 Jun 6.
Methods are required to identify abdominal aortic aneurysms (AAAs) at increased risk of rupture. Inflammatory characteristics of AAA can be visualised using advanced imaging techniques and have been proposed as potential predictors of aneurysm progression. The objective of this review was to determine which inflammatory imaging biomarkers are associated with AAA growth and rupture.
A systematic review was carried out in accordance with the PRISMA guidelines. The electronic databases of Medline (PubMed), Embase, and the Cochrane Library were searched up to January 1, 2016 for studies to determine the potential association between inflammatory imaging biomarkers and AAA growth or rupture.
Seven studies were included, comprising 202 AAA patients. (18)F-fluoro-deoxy-glucose positron emission tomography ((18)F-FDG PET-CT) was evaluated in six studies. Magnetic resonance imaging with ultrasmall superparamagnetic particles of iron oxide (USPIO-MRI) was evaluated in one study. Two of six (18)F-FDG PET-CT studies reported a significant negative correlation (r=.383, p = .015) or a significant negative association (p = .04). Four of six (18)F-FDG PET-CT studies reported no significant association between (18)F-FDG uptake and AAA growth. The single study investigating USPIO-MRI demonstrated that AAA growth was three times higher in patients with focal USPIO uptake in the AAA wall compared to patients with diffuse or no USPIO uptake in the wall (0.66 vs. 0.24 vs. 0.22 cm/y, p = .020). In the single study relating (18)F-FDG uptake results to AAA rupture, the association was not significant.
Current evidence shows contradictory associations between (18)F-FDG uptake and AAA growth. Data on the association with rupture are insufficient. Based on the currently available evidence, neither (18)F-FDG PET-CT nor USPIO-MRI can be implemented as growth or rupture prediction tools in daily practice. The heterogeneous results reflect the complex and partially unclear relationship between inflammatory processes and AAA progression.
需要有方法来识别破裂风险增加的腹主动脉瘤(AAA)。AAA的炎症特征可通过先进的成像技术显现出来,并且已被认为是动脉瘤进展的潜在预测指标。本综述的目的是确定哪些炎症成像生物标志物与AAA的生长和破裂相关。
按照PRISMA指南进行系统综述。检索了截至2016年1月1日的Medline(PubMed)、Embase和Cochrane图书馆的电子数据库,以查找确定炎症成像生物标志物与AAA生长或破裂之间潜在关联的研究。
纳入了7项研究,共202例AAA患者。6项研究评估了(18)F-氟脱氧葡萄糖正电子发射断层扫描((18)F-FDG PET-CT)。1项研究评估了超小型超顺磁性氧化铁颗粒磁共振成像(USPIO-MRI)。6项(18)F-FDG PET-CT研究中有2项报告了显著的负相关(r = 0.383,p = 0.015)或显著的负关联(p = 0.04)。6项(18)F-FDG PET-CT研究中有4项报告(18)F-FDG摄取与AAA生长之间无显著关联。调查USPIO-MRI的单项研究表明,与AAA壁弥漫性摄取或无摄取的患者相比,AAA壁局灶性摄取USPIO的患者AAA生长速度高3倍(0.66 vs. 0.24 vs. 0.22 cm/y,p = 0.020)。在将(18)F-FDG摄取结果与AAA破裂相关的单项研究中,该关联不显著。
目前的证据表明(18)F-FDG摄取与AAA生长之间的关联相互矛盾。与破裂相关的数据不足。基于目前可得的证据,在日常实践中,(18)F-FDG PET-CT和USPIO-MRI均不能作为生长或破裂的预测工具使用。结果的异质性反映了炎症过程与AAA进展之间复杂且部分尚不明确的关系。